These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 17052266)

  • 1. Anaerobic culture conditions favor biofilm-like phenotypes in Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
    O'May CY; Reid DW; Kirov SM
    FEMS Immunol Med Microbiol; 2006 Dec; 48(3):373-80. PubMed ID: 17052266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
    Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C
    J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression characteristics of a cystic fibrosis epidemic strain of Pseudomonas aeruginosa during biofilm and planktonic growth.
    Manos J; Arthur J; Rose B; Bell S; Tingpej P; Hu H; Webb J; Kjelleberg S; Gorrell MD; Bye P; Harbour C
    FEMS Microbiol Lett; 2009 Mar; 292(1):107-14. PubMed ID: 19222585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of biofilm formation in the susceptibility of Pseudomonas aeruginosa from Brazilian patients with cystic fibrosis.
    Ferreira AG; Leão RS; Carvalho-Assef AP; Folescu TW; Barth AL; Marques EA
    APMIS; 2010 Aug; 118(8):606-12. PubMed ID: 20666742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interspecies biofilms of Pseudomonas aeruginosa and Burkholderia cepacia.
    Tomlin KL; Coll OP; Ceri H
    Can J Microbiol; 2001 Oct; 47(10):949-54. PubMed ID: 11718549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of long-term co-administration of tobramycin and clarithromycin in a mature biofilm model of cystic fibrosis clinical isolates of Pseudomonas aeruginosa.
    Tré-Hardy M; Traore H; El Manssouri N; Vanderbist F; Vaneechoutte M; Devleeschouwer MJ
    Int J Antimicrob Agents; 2009 Oct; 34(4):370-4. PubMed ID: 19505804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients.
    Bjarnsholt T; Jensen PØ; Fiandaca MJ; Pedersen J; Hansen CR; Andersen CB; Pressler T; Givskov M; Høiby N
    Pediatr Pulmonol; 2009 Jun; 44(6):547-58. PubMed ID: 19418571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of oxygen limitation on the in vitro activity of levofloxacin and other antibiotics administered by the aerosol route against Pseudomonas aeruginosa from cystic fibrosis patients.
    King P; Citron DM; Griffith DC; Lomovskaya O; Dudley MN
    Diagn Microbiol Infect Dis; 2010 Feb; 66(2):181-6. PubMed ID: 19828274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population.
    Bradbury R; Champion A; Reid DW
    Respirology; 2008 Nov; 13(6):886-92. PubMed ID: 18811887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomonas aeruginosa biofilms in cystic fibrosis.
    Høiby N; Ciofu O; Bjarnsholt T
    Future Microbiol; 2010 Nov; 5(11):1663-74. PubMed ID: 21133688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucoid Pseudomonas aeruginosa isolates maintain the biofilm formation capacity and the gene expression profiles during the chronic lung infection of CF patients.
    Lee B; Schjerling CK; Kirkby N; Hoffmann N; Borup R; Molin S; Høiby N; Ciofu O
    APMIS; 2011 Apr; 119(4-5):263-74. PubMed ID: 21492226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.
    Murray TS; Egan M; Kazmierczak BI
    Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical response to azithromycin in cystic fibrosis correlates with in vitro effects on Pseudomonas aeruginosa phenotypes.
    Nguyen D; Emond MJ; Mayer-Hamblett N; Saiman L; Marshall BC; Burns JL
    Pediatr Pulmonol; 2007 Jun; 42(6):533-41. PubMed ID: 17469154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways.
    Hassett DJ; Sutton MD; Schurr MJ; Herr AB; Caldwell CC; Matu JO
    Trends Microbiol; 2009 Mar; 17(3):130-8. PubMed ID: 19231190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How much do Pseudomonas biofilms contribute to symptoms of pulmonary exacerbation in cystic fibrosis?
    VanDevanter DR; Van Dalfsen JM
    Pediatr Pulmonol; 2005 Jun; 39(6):504-6. PubMed ID: 15830388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of clonal strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients in Ontario, Canada.
    Beaudoin T; Aaron SD; Giesbrecht-Lewis T; Vandemheen K; Mah TF
    Can J Microbiol; 2010 Jul; 56(7):548-57. PubMed ID: 20651854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR; Pressler T; Høiby N
    J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance.
    Salunkhe P; Smart CH; Morgan JA; Panagea S; Walshaw MJ; Hart CA; Geffers R; Tümmler B; Winstanley C
    J Bacteriol; 2005 Jul; 187(14):4908-20. PubMed ID: 15995206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-sectional analysis of clinical and environmental isolates of Pseudomonas aeruginosa: biofilm formation, virulence, and genome diversity.
    Head NE; Yu H
    Infect Immun; 2004 Jan; 72(1):133-44. PubMed ID: 14688090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron-binding compounds impair Pseudomonas aeruginosa biofilm formation, especially under anaerobic conditions.
    O'May CY; Sanderson K; Roddam LF; Kirov SM; Reid DW
    J Med Microbiol; 2009 Jun; 58(Pt 6):765-773. PubMed ID: 19429753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.